While America continues to waste put its money into Embryonic Stem Cell research, a doctor in Iraq is actually treating patients with their own Adult Stem Cells. Dr. Abdul Majeed Alwan Hammadi is treating patients for free- and has so far treated 34 patients with stem cell therapy and treatment, mainly patients with Multiple […]
Regenerative medicine took a step forward on Monday with the announcement of the creation of the first disease-specific line of embryonic stem cells made with a patient’s own DNA (…)
“This is a really important step forward in our quest to develop healthy, patient-specific stem cells that can be used to replace cells that are diseased or dead,” said Susan Solomon, chief executive officer of NYSCF, which she co-founded in 2005 partly to search for a cure for her son’s diabetes.
Stem cells could one day be used to treat not only diabetes but also other diseases, such as Parkinson’s and
A new method to reprogram adult cells making them similar to stem cells has been discovered. The key protein in the discovery is Wnt, already known to scientists for its involvement in numerous phases of development in vertebrates and invertebrates. The study, conducted by the Telethon Institute of Genetics and Medicine (TIGEM) in Naples by Maria Pia Cosma, was published in the online version of Cell Stem Cell magazine. The study involved various types of adult cells including fibroblasts, thymus cells, and neural precursor cells, which were fused with embryonic stem cells in the presence of the
Image via Wikipedia
BioTime Inc.announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks. Derived from human embryonic stem cells but not fully differentiated into specific cell types, each ACTCellerate™ line provides a convenient, highly purified source of progenitor cells that may
British scientists have reportedly perfected the technique for curing macular-degeneration related blindness with adult stem cells. Returning Hope, a pioneering Asian adult stem cell treatment portal, expects to be one of the first in the world to offer the treatment.
Researchers from the Institute of Ophthalmology at London’s University College used embryonic eye stem cells to replace the layer of damaged eye cells. While Pfizer is backing the British push to bring the therapy to patients, Brian Dardzinski, CEO of Returning Hope, expects that Adult Stem Cell treatments will be available both much sooner and much cheaper in Thailand.